The Burrill Report
Download your complimentary copy of the January 2012 issue of The Burrill Report .
News
Biotech Dealmaking Gets off to a Strong Start in 2012 February 01, 2012 | Press Release
Burrill & Company Announces Close of Burrill Brazil Fund I January 18, 2012 | Press Release
David Wetherell Joins Burrill & Company Venture Capital Group as Managing Director January 06, 2012 | Press Release
See all News
Burrill & Company Advises Samsung in Biosimilars Joint Venture Agreement with Biogen Idec
December 06, 2011
Biotech Visionary G. Steven Burrill Honored With Breath of Life Award From the Northern California Chapter of the Cystic Fibrosis Foundation
November 14, 2011
Debt Worries, Political Dysfunction Take a Toll on Biotech in Third Quarter
Biotech stocks fall with the market as financing activity slows
October 03, 2011
Promise of Personalized Medicine Remains Unrealized
Burrill & Company Meeting Explores the Challenges Faced by the Drugs, Tools, and Diagnostics Companies Leading a Revolution in Healthcare
September 15, 2011
Volatile Markets in August Take a Toll on Life Sciences IPOs
Burrill & Company says poor performance for new issues, depressed stocks, could fuel surge in M&A
August 31, 2011
New Drug Approvals in 2011 Already Match 2010 Total
Burrill & Company sees environment improving for life sciences, but macroeconomic threats persist.
July 31, 2011
Burrill & Company Appoints New Head of Its Merchant Banking Group and Augments Its Group
June 06, 2011
Meet Top Biotech Executives at The Burrill Latin America Life Sciences, May 19-20 in Rio
May 17, 2011
M&A Has Failed to Build Value for Pharma, Burrill Annual Biotech Report Finds
Pressure to Find Better Models to Discover and Develop New Drugs Increases
April 12, 2011
G. Steven Burill Discusses His New Book Biotech 2011-Life Sciences: Looking Back to See Ahead
March 24, 2011
Boom Times for Genomics Startups
Investment is picking up as sales of gene sequencing machines surge
March 17, 2011
Dirk Lammerts joins Burrill Venture Capital Group
Focus will be on building the company’s activities in digital health
March 10, 2011
Burrill & Company and Infinity Group Form Joint Venture Focusing on Life Science Opportunities in China
October 12, 2010
Executive Mindshare Announces New Social Media Platform for Vertical Business Networks
September 15, 2010
Biotech posts strong first quarter gain
Industry benefits from healthcare reform and robust general markets
April 01, 2010
Burrill & Company and WR Hambrecht + Co to collaborate on OpenIPO® transactions
Joint venture will focus on select healthcare companies
October 09, 2009
FDA Commissioner Dr. Margaret Hamburg headlines at the Burrill Annual Personalized Medicine Meeting
September 16, 2009
NewBridge Pharmaceuticals Announces Licensing of Pylera® for Middle East, Africa, Turkey & Caspian Region
July 22, 2009
Burrill Merchant Banking Advises Adlyfe on Alzheimer’s Biomarker Partnership with Wyeth
March 17, 2009
Biotech Industry Turns a Profit for the First Time, But Milestone Overshadowed as Companies Struggle for Survival, Report Finds
February 25, 2009
Burrill Merchant Banking advises Mitsubishi Tanabe Pharma Corporation on transactions with Cytochroma Inc.
September 08, 2008
Biotech red hot in July as potential blockbuster M&A deals awake investors from their summer slumber
August 01, 2008
Burrill Merchant Banking Advises QLT USA on divestment of QLT USA, INC.'s Generic Dermatology and Manufacturing Business
April 12, 2007
Hal Gerber, M.D Joins Burrill & Company’s Merchant Banking Group To Further Expand M&A Services
August 01, 2005
Biotech Recognized as One of San Francisco Mayor Gavin Newsom's First Year Accomplishments
January 07, 2005
Burrill & Company's Merchant Banking Practice Announces Increasing Spin-Out Activity From Pharmaceutical Companies
January 07, 2005
Burrill & Company Announces Promotions and Organizational Changes to Reflect the Growth of its Business
January 05, 2005
G. Steven Burrill is Recognized as Biotech Investment Visionary by Scientific American
November 20, 2002